Fz Lle Inter M. - 18 Aug 2022 Form 4 Insider Report for Bakhu Holdings, Corp.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2022, 16:11:31 UTC
Prior SEC filing
08 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Petros Charalambous, Managing Director

Key filing fact

Fz Lle Inter M. filed Form 4 for Bakhu Holdings, Corp. on 08 Sep 2022.

Key facts

  • This page summarizes Fz Lle Inter M.'s Form 4 filing for Bakhu Holdings, Corp..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2022, 16:11.

Change

  • Previous filing in this sequence was filed on 08 Sep 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BKUH transaction

Stock Option

Gift

Transaction value
$0
Shares
+216,445
Change %
+0.19%
Price
$0.000000
Shares after
116,783,555
Date
18 Aug 2022
Ownership
Direct
BKUH holding

Series A Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4
Date
18 Aug 2022
Ownership
Cell Science Holding Ltd.
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Cell Science Holding Ltd., is the owner of 4 shares of Series A Preferred Stock. Cell Science is owned 40% by Inter-M Traders FZ LLE, 30% by the OZ Corporation and 30% by Mentone Ltd., all of whom are deemed to be the beneficial owners of the 4 shares of Series A Preferred Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .